Dr. Reddy's Q3 & 9M FY24 Financial Results -January 31, 2024 at 09:45 am EST

Dr. Reddy’s Laboratories Ltd. today announced its consolidated financial results for the quarter and nine months ended December 31, 2023. The information mentioned in this release is based on...

Related Keywords

Germany ,Brazil ,Hyderabad ,Andhra Pradesh ,India ,Hong Kong ,Singapore ,Romania ,United Kingdom ,China ,Russia ,United States ,America , ,International Toll ,International Financial Reporting Standards ,Reddy Laboratories Limited Subsidiaries ,Exchange Commission ,Good Health Cant Wait ,Reddy Laboratories Ltd ,World Economic Forum ,Research Development ,Drug Administration ,Active Ingredients ,India Yoy ,Earnings Per Share ,Coya Therapeutics ,Investigational Combination Therapy ,Amyotrophic Lateral Sclerosis ,Pre Approval Inspection ,Dow Jones Sustainability World Index ,Emerging Markets Index ,Gold Medal ,Golden Peacock ,Corporate Social Responsibility ,Corporate Governance ,Social Responsibility Excellence ,North America ,Abbreviated New Drug Applications ,Master Files ,Statement Highlights ,Income Tax Act ,Working Capital ,Investment Income ,Before Interest ,Capital Employed ,Access Number ,Toll Free Number ,Playback Code ,Sustainability Report ,Annual Report ,Markets ,